AN ANTISENSE OLIGONUCLEOTIDE TO THE HSV-1 UL-13 GENE IS EFFECTIVE AGAINST HERPETIC-KERATITIS

被引:0
|
作者
BRANDT, CR
COAKLEY, LM
GRAU, DR
DRAPER, KG
机构
[1] UNIV MINNESOTA,DEPT OPHTHALMOL,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,DEPT MICROBIOL IMMUNOL,MINNEAPOLIS,MN 55455
[3] ISIS PHARMACEUT,CARLSBAD,CA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:854 / 854
页数:1
相关论文
共 50 条
  • [41] A Mutation in the Herpes Simplex Virus Type 1 (HSV-1) UL29 Gene is Associated with Anti-Herpesvirus Drugs' Susceptibility
    Yamada, Souichi
    Harada, Shizuko
    Fujii, Hikaru
    Kinoshita, Hitomi
    Nguyen, Phu Hoang Anh
    Shibamura, Miho
    Yoshikawa, Tomoki
    Kawahara, Madoka
    Ebihara, Hideki
    Saijo, Masayuki
    Fukushi, Shuetsu
    VIRUSES-BASEL, 2024, 16 (12):
  • [42] Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): Analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles
    Everly, DN
    Read, GS
    JOURNAL OF VIROLOGY, 1999, 73 (11) : 9117 - 9129
  • [43] A Single Intramuscular Vaccination of Mice with the HSV-1 VC2 Virus with Mutations in the Glycoprotein K and the Membrane Protein UL20 Confers Full Protection against Lethal Intravaginal Challenge with Virulent HSV-1 and HSV-2 Strains
    Stanfield, Brent A.
    Stahl, Jacque
    Chouljenko, Vladimir N.
    Subramanian, Ramesh
    Charles, Anu-Susan
    Saied, Ahmad A.
    Walker, Jason D.
    Kousoulas, Konstantin G.
    PLOS ONE, 2014, 9 (10):
  • [44] Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs
    Cha, SC
    Kim, YS
    Cho, JK
    Cho, J
    Kim, SY
    Kang, H
    Cho, MH
    Lee, HH
    VIRUS RESEARCH, 2002, 86 (1-2) : 21 - 31
  • [45] The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice
    Augustinova, H
    Hoeller, D
    Yao, F
    JOURNAL OF VIROLOGY, 2004, 78 (11) : 5756 - 5765
  • [46] Identification of Liver Specific Gene Promoters for Transcriptional Targeting of HSV-1 Oncolytic Viruses Against Hepatocellular Carcinoma
    Pourchet, Aldo
    Foka, Pelagia
    Doumba, Polyxeni
    Biollay, Coline
    Melendez, Matias
    Koskinas, Ioannis
    Mavromara, Penelope
    Epstein, Alberto L.
    HUMAN GENE THERAPY, 2009, 20 (06) : 673 - 674
  • [47] Cloning and sequence analysis of a Marek's disease virus (MDV) gene homolog to herpes simplex virus type 1 (HSV-1) UL9
    Wu, TF
    Coussens, P
    CURRENT RESEARCH ON MAREK'S DISEASE, 1996, : 436 - 441
  • [48] In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model
    Anand, BS
    Hill, JM
    Dey, S
    Maruyama, K
    Bhattacharjee, PS
    Myles, ME
    Nashed, YE
    Mitra, AK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (06) : 2529 - 2534
  • [49] Improved long-term expression from helper virus-free HSV-1 vectors packaged using combinations of mutated HSV-1 proteins that include the UL13 protein kinase and specific components of the VP16 transcriptional complex
    Liu, Meng
    Wang, Xiaodan
    Geller, Alfred I.
    BMC MOLECULAR BIOLOGY, 2009, 10
  • [50] Restitution of the UL56 gene expression of HSV-1 HFEM led to restoration of virulent phenotype; Deletion of the amino acids 217 to 234 of the UL56 protein abrogates the virulent phenotype
    Kehm, R
    RosenWolff, A
    Darai, G
    VIRUS RESEARCH, 1996, 40 (01) : 17 - 31